AXL and breast cancer: In addition to downregulating pro-epithelial factors and inducing mesenchymal markers, AXL enhances the transcriptional expression of EMT regulators Slug and N-cadherin by activating PI3K and NF-κβ pathways.77,84 Overexpression of AXL in primary breast cancers is associated with reduced patient survival.